טוען...
Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib
Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important category of thrombotic microangiopathies (TMAs). Cancer therapeutic agents including proteasome inhibitors (PIs) are among the most common medications reported to cause DTMA. PIs could cause DTMA eith...
שמור ב:
| הוצא לאור ב: | Case Rep Hematol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6051099/ https://ncbi.nlm.nih.gov/pubmed/30057831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7063145 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|